at 08:10 |
|
|
Sangamo Therapeutics, Inc. , a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo's deep expertise in protein-DNA...
|
at 08:09 |
|
|
Aquilance, a leading provider of financial administration services for high-net-worth families, individuals, and family offices, continues to gain recognition for its proprietary technology and white glove service. This year, the firm is proud to...
|
at 08:06 |
|
|
Academy Sports + Outdoors ("Academy") today announced the donation of over $530,000 to St. Jude Children's Research Hospital®. The donation is a result of a collaboration between the two organizations to create holiday-inspired t-shirts and pajamas...
|
at 08:05 |
|
|
Researchers from Mind Medicine (MindMed) Inc. (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today presented new studies highlighting the significant...
|
at 08:05 |
|
|
ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company's ongoing growth and dedication to...
|
at 08:05 |
|
|
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.
"2024 is off to a great start with tremendous progress on our skeletal...
|
|
|